• Pancreatic ductal adenocarcinoma (PDA) is characterized by its highly immunosuppressive tumor microenvironment (TME) that limits T cell infiltration and induces T cell hypofunction. (jci.org)
  • Pancreatic ductal adenocarcinoma is one of the most challenging cancers to treat and has a high mortality rate. (cytologicsbio.com)
  • The two types of pancreatic carcinoma are acinar cell carcinoma and ductal adenocarcinoma . (cancer.gov)
  • Pancreatic ductal adenocarcinoma-derived exosomes were observed with a high expression on the macrophage migration inhibitory element, which promoted a premetastatic niche in liver and metastasis at a later stage [29]. (glucagon-receptor.com)
  • Targeting a single pathway in pancreatic adenocarcinoma (PC) is unlikely to affect its natural history. (elsevierpure.com)
  • The investigators focused on patients who had an indication for elective distal pancreatectomy plus splenectomy due to proven or highly suspected pancreatic ductal adenocarcinoma in the pancreatic body or tail. (medscape.com)
  • Aberrant expression of CA125/MUC16 is associated with pancreatic ductal adenocarcinoma (PDAC) progression and metastasis. (unc.edu)
  • The role of radiochemotherapy in the multimodal treatment of pancreatic ductal adenocarcinoma: Standard procedure or individual decision? (springermedizin.at)
  • Pancreatic ductal adenocarcinoma has a poor clinical outcome and responses to immunotherapy are suboptimal. (elifesciences.org)
  • The plasticity and heterogeneity of fibroblasts in the tumor microenvironment of pancreatic ductal adenocarcinoma (PDAC) has emerged as a key factor in determining tumor growth and therapeutic response. (elifesciences.org)
  • PURPOSE: Pancreatic adenocarcinoma is currently the fourth leading cause of cancer death in the United States, and most pancreatic cancers develop locally advanced disease or metastasis at the time of diagnosis. (duke.edu)
  • It is administered through intravenous route.It was under development for solid tumors including pancreatic ductal adenocarcinoma, gastric cancer, colorectal cancer, melanoma, head and neck cancer squamous cell carcinoma, Ewing sarcoma and gastrointestinal stromal tumors. (globaldata.com)
  • Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, is used for maintenance therapy in pancreatic adenocarcinoma. (medscape.com)
  • Olaparib has US Food and Drug Administration (FDA) approval for adults with germline BRCA -mutated metastatic pancreatic adenocarcinoma whose disease has not progressed on at least 16 weeks of a first-line platinum-based chemotherapy regimen. (medscape.com)
  • It is indicated for maintenance treatment of adults with deleterious or suspected deleterious gBRCAm metastatic pancreatic adenocarcinoma whose disease has not progressed on at least 16 weeks of a first-line platinum-based chemotherapy regimen. (medscape.com)
  • However, cancers including pancreatic ductal adenocarcinoma (PDA) and microsatellite stable colorectal carcinoma (MSS CRC) have on average only 50-70 expressed mutations per exome and do not respond to single-agent ICIs. (aacrjournals.org)
  • T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma. (aacrjournals.org)
  • Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy. (rochester.edu)
  • Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinoma. (rochester.edu)
  • Biological assays were performed on well-[Ishikawa (ISH)] moderately (MFE-296) and poorly (MFE-280) differentiated human adenocarcinoma cancer cell lines, representing the G1, G2 and G3 stage of EC. (spandidos-publications.com)
  • The etiology of pancreatic ductal adenocarcinoma (PDAC) is poorly understood, and treatment is largely ineffectual because of the advanced stage of disease at presentation. (nih.gov)
  • Mutations in which of the following genes are commonly found in pancreatic adenocarcinoma? (medscape.com)
  • Mutations in all of the genes listed in slide 4 are found in pancreatic adenocarcinoma. (medscape.com)
  • We used the pancreatic adenocarcinoma cell line PANC-1 as a model to apply different chemotherapeutic protocols (monotherapy and combined therapy) using 5-Fluorouracil, Oxaliplatin, Irinotecan, Gemcitabine and Abraxane. (isciii.es)
  • Pancreatic adenocarcinoma, the malignant neoplasm of the exocrine duct cells, accounts for more than ninety percent of all pancreatic tumors (Ref.1). (proteinlounge.com)
  • Pancreatic ductal adenocarcinoma evolves from a progressive cascade of cellular, morphological and architectural changes from normal ductal epithelium through pre-neoplastic lesions termed PanIN (Pancreatic Intraepithelial Neoplasia). (proteinlounge.com)
  • A dynamic portrait of metabolic profiles known as "metabolomics" has been used to identify new blood-derived metabolite biomarkers that can distinguish between pancreatic ductal adenocarcinoma and chronic pancreatitis with a high degree of accuracy and at an earlier disease stage than conventional diagnostic testing, researchers say. (medscape.com)
  • The current 5-year survival rate for pancreatic adenocarcinoma is about 6%, and pancreatic cancer is projected to be the third leading cause of cancer-related death by 2030, thanks to delayed diagnosis and few new treatment options, the researchers note. (medscape.com)
  • See Pancreatic Adenocarcinoma Imaging: What You Need to Know , a Critical Images slideshow, to help identify which imaging studies to use to identify and evaluate this disease. (medscape.com)
  • NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma. (medscape.com)
  • Western blotting was employed to determine NGF level in PC and paracarcinoma tissues and in PC cell lines as well as pancreatic ductal epithelial cells. (hindawi.com)
  • With a prevalence of 80-85%, ductal adenocarcinomas are far more common than all other histologic subtypes of pancreatic cancer. (medscape.com)
  • These tumors are also called pancreatic neuroendocrine tumors (pancreatic NETs). (cancer.gov)
  • In children, some pancreatic tumors do not secrete hormones and there are no signs and symptoms of disease. (cancer.gov)
  • Pancreatic tumors that do secrete hormones may cause signs and symptoms. (cancer.gov)
  • A pancreatic neuroendocrine tumor (NET) is a type of cancer that forms tumors in the pancreas. (hopkinsmedicine.org)
  • Subtotal pancreatectomy with enucleation: With insulinomas associated with multiple endocrine neoplasia type 1 (MEN1), subtotal pancreatectomy with enucleation of tumors from the pancreatic head and uncinate process often is necessary because of frequent multiple tumors in MEN1. (medscape.com)
  • Approaches that turn currently unresponsive cancers into ones that are more "antigenic" are needed to sensitize tumors to ICIs. (aacrjournals.org)
  • Pancreatic tumors have few blood vessels, and tumor blood flow is sluggish. (ascopost.com)
  • Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment. (rochester.edu)
  • Treating the brain with a preventative course of radiation may help Small Cell Lung Cancer (SCLC) patients - whose tumors often spread to their brain -- live longer, according to a new study from researchers in the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania. (news-medical.net)
  • New research shows that current approaches to genome analysis systematically miss detecting a certain type of complex mutation in cancer patients' tumors. (news-medical.net)
  • Approximately 80% of all pancreatic cancers are adenocarcinomas, with only 2% of exocrine pancreatic tumors diagnosed as benign. (medscape.com)
  • Breast cancers are most often epithelial tumors involving the ducts or lobules. (msdmanuals.com)
  • General references Breast cancers are most often epithelial tumors involving the ducts or lobules. (msdmanuals.com)
  • Functional malignant cell heterogeneity in pancreatic neuroendocrine tumors revealed by targeting of PDGF-DD. (lu.se)
  • Here, making use of a newly generated Pdgfd knockout mouse, we reveal a functionally important malignant cell heterogeneity modulated by PDGF-DD signaling in pancreatic neuroendocrine tumors (PanNET). (lu.se)
  • Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727). (elsevierpure.com)
  • We tested the hypothesis that simulataneous targeting of the epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor-1 (IGF-1R) pathways would significantly improve progression-free survival (PFS) by abrogating reciprocal signaling that promote drug resistance This was a phase Ib/II study testing cixutumumab, combined with erlotinib and gemcitabine (G) in patients with untreated metastatic PC. (elsevierpure.com)
  • The encoded protein is a subunit of the receptor for interleukin 20, a cytokine that may be involved in epidermal function. (nih.gov)
  • Epidermal growth factor receptor-targeted treatment strategies in advanced pancreatic cancer: Is K-RAS mutational testing ready for prime time? (springermedizin.at)
  • This agent is pharmacologically classified as a human epidermal growth factor receptor type 1/epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor. (medscape.com)
  • Erlotinib is a type of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. (news-medical.net)
  • Findings from a phase III clinical trial point to a potential new treatment for patients newly diagnosed with advanced, epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCLC). (news-medical.net)
  • This is the first FDA-approved, blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer patients. (news-medical.net)
  • Airway epithelial epidermal growth factor receptor mediates hogbarn dust-induced cytokine release but not Ca2+ response. (cdc.gov)
  • this may be in part because they have a higher rate of triple-negative breast cancer (negative for estrogen and progesterone receptors and human epidermal growth factor receptor [HER2] oncogene), which has a poorer prognosis than other types. (msdmanuals.com)
  • Immunotherapy for patients with cancer involves the use of immune cells, often the patient's own cells, to develop a treatment to target tumor cells. (cytologicsbio.com)
  • To engineer T cells targeting mutant KRAS protein, T-cell receptors were isolated from the previously treated patient with colorectal cancer, synthesized, and cloned for use to transduce the PBMCs. (cytologicsbio.com)
  • Over 90% of the cells expressed the mutant KRAS neoantigen-specific T-cell receptors. (cytologicsbio.com)
  • Pancreatic Cancer may be vulnerable to engineered T cells that recognize a "hot-spot" mutation called KRAS G12D. (cytologicsbio.com)
  • The approach could also be adapted to engineer cells targeting other tumor specific neoantigens that may be more important in a given cancer. (cytologicsbio.com)
  • Pancreatic cancer is a disease in which malignant (cancer) cells form in the tissues of the pancreas. (cancer.gov)
  • Pancreatic cancer CB1 Activator supplier cell-derived exosomes inhibited immune response through miR-203 and hence downregulated Toll-like receptors, and downstream cytokines like tumor necrosis factor-alpha (TNF-) and IL-12 in dendritic cells (DC) [27]. (glucagon-receptor.com)
  • The fibroblast-secreted exosome component CD81 in addition to Wnt-planar cell polarity signaling in breast cancer cells induced protrusive activity and enhanced metastasis and motility [28]. (glucagon-receptor.com)
  • In a further study, exosomes derived from hugely metastatic human oral cancer cells had been identified to transfer two onco-miRs, miR-1246 and miR-342-3p, to poorly metastatic cells at adjacent or distance websites and induced increased cell motility and invasive capacity [35]. (glucagon-receptor.com)
  • Typical cell-derived exosomes transferred extended ncRNA (lncRNA) PTENP1 to bladder cancer cells, which reduced tumor progression each in vitro and in vivo [48]. (glucagon-receptor.com)
  • Other exosomal miRNAs like miR-144 [49] and miR-520b [50] inhibited non-small cell lung cancer (NSCLC) progression by means of the downregulation of cyclin E1 and E2 migration of pancreatic cancer cells, respectively. (glucagon-receptor.com)
  • Exosomal miR-497 suppressed the migratory properties of lung cancer cells by means of the inhibition of development things and cyclin E1 [51]. (glucagon-receptor.com)
  • Exosomal miR-375 inhibited cell proliferation and the invasive properties of colon cancer cells [53]. (glucagon-receptor.com)
  • IBC is characterised by the presence of cancer cells in the subdermal lymphatics on skin biopsy. (wikipedia.org)
  • This receptor has been shown to be important for B-lineage maturation and antigen-driven B-cell differentiation, and it may regulate the migration and recruitment of dentritic and T cells during inflammatory and immunological responses. (cancerindex.org)
  • Hypoxia stimulates cancer cells to acquire a more malignant phenotype via activation of hypoxia-inducible factor 1 (HIF-1). (cancerindex.org)
  • Given that cancer cells and astrocytes in glioblastomas coexist in a hypoxic microenvironment, we examined whether astrocytes affect the adaptation of glioblastoma cells to hypoxia. (cancerindex.org)
  • The expression of HIF-1 downstream genes, cancer colony formation, and Matrigel invasion of glioblastoma cells were stimulated by conditioned medium from astrocytes pre-exposed to hypoxia. (cancerindex.org)
  • This is a surgery that removes cells so they can be checked under a microscope to look for cancer. (hopkinsmedicine.org)
  • Decoy receptor 3 (DcR3) is highly expressed in various cancer cells and plays a significant role in immune suppression and tumor progression. (academicjournals.org)
  • However, how DcR3 expression is modulated in pancreatic cancer cells is enigmatic. (academicjournals.org)
  • 3′-(4, 5 dimethyl-thiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay and flow cytometric analysis were used to measure cell proliferation and apoptosis, respectively in the human pancreatic cancer Capan-1 cells. (academicjournals.org)
  • Besides, NGF binding to TrkA receptors encouraged the intracellular Warburg effect in PC and DRG cells. (hindawi.com)
  • Sensitization of cancer cells to conventional drugs using multi-target agents that block survival and oncogenic pathways, alone or in combination, is an emerging strategy to overcome drug resistance. (researchsquare.com)
  • Cancer is characterized as the uncontrolled multiplication and spread of the body's particular cells. (researchsquare.com)
  • Not only do these wrap pancreatic tumours in a dense, protective layer, they also foster complex relationships with the cancerous cells: some fibroblasts may fuel tumour growth, while other may help to contain its spread. (elifesciences.org)
  • Being able to specifically eliminate pro-cancer fibroblasts requires a better understanding of the factors that shape the role of these cells, and how to identify them. (elifesciences.org)
  • Scholars@Duke publication: Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. (duke.edu)
  • EGFR is expressed on the cell surface of normal cells and cancer cells. (medscape.com)
  • Immune checkpoint inhibitors (ICIs) are providing durable clinical responses in about 20% of cancer patients, but these agents have minimal effect in cancers without intratumoral T cells. (aacrjournals.org)
  • Tumor genome mutations can express mutant proteins that are tumor-specific and not expressed on normal cells (neoantigens), and cancers with the highest mutational burdens are more likely to respond to single-agent ICIs. (aacrjournals.org)
  • However, most cancers have lower mutational loads resulting in lower antigenicity, weaker endogenous T-cell repertoires, and T cells in the tumor. (aacrjournals.org)
  • Emerging data suggest that it should be possible to develop precision immunology approaches that combine a neoantigen targeting vaccine to activate and expand the limited repertoire of T cells specific for the expressed neoantigens found in low-mutation cancers, with ICIs to induce clinically relevant antitumor responses. (aacrjournals.org)
  • Desmoplasia is a scar-like structure in the stroma around cancer cells unique to pancreatic cancer. (ascopost.com)
  • Efforts to target desmoplasia focus on modifying the fibroblasts-cells that produce the stroma-and blocking the ability of fibroblasts to create desmoplasia and other cells that promote cancer cells and immune evasion, leading to cachexia. (ascopost.com)
  • In keeping with the metaphors of flame and fire, Dr. Tuveson continued, "dysregulated metabolism is the pot on the stove making food to feed the hungry pancreatic cancer cells. (ascopost.com)
  • Dr. Dafna Bar-Sagi discovered that the surviving pancreatic cancer cells eat the stromal proteins surrounding it, and this protein breaks down inside the cell into amino acids that fuel cell division. (ascopost.com)
  • There are several approaches to blocking the pancreatic cancer cells' ability to eat the protein. (ascopost.com)
  • In our lab, we are studying a process by which pancreatic cancer cells lower the amount of oxygen, producing reactive oxygen species," Dr. Tuveson said. (ascopost.com)
  • Moderate levels of reactive oxygen species facilitate carcinogenesis, but excessive levels are damaging to cancer cells. (ascopost.com)
  • They are also able to use a new generation of powerful drugs that are much more effective at targeting and destroying cancer cells. (marketresearchfuture.com)
  • We also showed that dose-dependent induction of proliferation was connected with changes in the expression of MKI67, CCND1 and CCNE1 genes in well- and poorly differentiated cancer cells. (spandidos-publications.com)
  • Our study revealed that Ang II influences EC cells in terms of cancer-related processes, and is responsible for increased proliferation, reduction in apoptosis, increased mobility and modulation of adhesion potential. (spandidos-publications.com)
  • Recently, a number of studies have shown that Ang II plays an important role in proliferation, invasiveness and migration of tumour cells, alteration of expression of cancer-related genes, as well as in physiological tissue remodelling. (spandidos-publications.com)
  • The aim of the present study was to evaluate the influence of Ang II on human endometrial cancer cells. (spandidos-publications.com)
  • Understanding the mechanisms that give cancer cells the ability to survive and grow opens the possibility of developing improved treatments to control or cure the disease. (news-medical.net)
  • Chen J, Wang S, Jia S, Ding G, Jiang G, Cao L. Integrated Analysis of Long Non-Coding RNA and mRNA Expression Profile in Pancreatic Cancer Derived Exosomes Treated Dendritic Cells by Microarray Analysis. (jcancer.org)
  • Cancer stem cells are responsible for tumor chemoresistance and recurrence in adjuvant and metastatic settings. (isciii.es)
  • The objective of this article was to evaluate how these chemotherapeutic regimens affect the proportion of cancer stem cells and the expression of stemness markers. (isciii.es)
  • After analyzing different tumor stem cell markers (SOX2, OCT4, CD133, CD44 and CD24) in pancreatic cancer cells treated with different chemotherapeutic protocols by means of RT-qPCR, Oxaliplatin and Gemcitabine in monotherapy were the chemotherapies that selected the most cancer stem cells while the FOLFIRI protocol decreased them. (isciii.es)
  • Recurrence and chemoresistance in pancreatic cancer are largely related to cancer stem cells. (isciii.es)
  • These mediators and their receptors are enriched in colon cancer cells and colon cancer tissues, which demonstrate there, contribute to tumor development and progression. (lu.se)
  • Now, she is interested in the interaction between the immune cells (mainly mast cells) present in the colon cancer microenvironment and colon cancer cells. (lu.se)
  • She is investigating two different ligands and their receptive G-protein coupled receptors WNT5A/Frizzle and cysteinyl leukotriene C4/CysLTR2 signaling pathways which both upregulates 15-PGDH and induce re-differentiation of colon cancer cells. (lu.se)
  • Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring. (who.int)
  • The finding that pancreatic cancers also have KRAS mutations led the research group to explore whether T-cell receptor gene therapy that targets mutant KRAS proteins (neoantigens), could provide a positive therapeutic response for patients with pancreatic cancer as well. (cytologicsbio.com)
  • excessive citations] Inflammatory breast cancer is a high-grade aneuploid cancer, with mutations and overexpression of p53, high levels of E-cadherin and abnormal cadherin function. (wikipedia.org)
  • Further, a significant percentage of these complex mutations are found in well-known cancer genes that could be targeted by existing drugs, potentially expanding the number of cancer patients who may benefit. (news-medical.net)
  • [3] A general rule for the genetic onset of pancreatic cancer is that multiple combinations of genetic mutations are present in adenocarcinomas. (medscape.com)
  • Mutations in K- ras are found in more than 90% of diagnosed pancreatic cancers. (medscape.com)
  • Mutations in P16 are seen in 80-95% of diagnosed pancreatic cancers. (medscape.com)
  • Genomic instability creates a permissive state in which a potential cancer cell is allowed to acquire enough mutations to become a cancer cell. (proteinlounge.com)
  • MSI occurs in approximately 15% of colon cancers and results from inactivation of the MMR (Mismatch Repair) system secondary to either MMR gene mutations or hypermethylation of MMR gene promoters. (proteinlounge.com)
  • Although many efforts in cancer prevention and control have routinely focused on behavioral risk factors, such as tobacco use, or on the early detection of cancer, such as colorectal cancer screening, advances in genetic testing have created new opportunities for cancer prevention through evaluation of family history and identification of cancer-causing inherited mutations. (cdc.gov)
  • Mutations in these genes are associated with increased risk for breast, ovarian, prostate, and pancreatic cancers ( 2 ). (cdc.gov)
  • Each year, BRCA1 and BRCA2 mutations account for 3% of all breast cancers and 10% of all ovarian cancers ( 3 ). (cdc.gov)
  • Mutations in these genes are associated with increased risk for certain cancers, including colorectal cancer, and cancers of the endometrium and ovary ( 7 ). (cdc.gov)
  • [ 1 ] Clinical researchers in this collaboration developed autologous TILs to treat a colorectal cancer patient which led to regression of metastases. (cytologicsbio.com)
  • MiRNAs for example colorectal cancer cell-derived exosomal miR-934 interacted with tumor-associated macrophages and induced premetastatic niche formation by means of the polarization of M2 macrophages and in the end brought on colorectal cancer liver metastasis [34]. (glucagon-receptor.com)
  • IPN-01087 is under development for recurrent head and neck squamous cell carcinoma, pancreatic, neuroendocrine prostate, colorectal, gastric and Ewing sarcoma.It is an radioconjugate combining actinium-225 with IPN-1087. (globaldata.com)
  • Colorectal cancer represents a relatively well-characterized tumorigenesis paradigm and colorectal carcinoma is one of the leading causes of cancer-related death. (proteinlounge.com)
  • Colorectal cancer results from the accumulation of genetic alterations. (proteinlounge.com)
  • The Genomic Landscape of Colorectal Cancer in the Saudi Arabian Population Using a Comprehensive Genomic Panel. (cdc.gov)
  • Syrina is a pharmacist and her research in cell pathology focuses on neutrophils recruitment in colorectal cancers microenvironment and in cancer related inflammation. (lu.se)
  • It´s still not clear what role the infiltration of neutrophils in colorectal cancer have and how many types of neutrophils exist that interact with cancer and its effect on CRC microenvironment. (lu.se)
  • Each year, Lynch syndrome accounts for 1%-3% of all colorectal cancer cases ( 8 ). (cdc.gov)
  • The risk for colorectal cancer among persons with Lynch syndrome is substantially higher than that of the general population (Table 1) ( 9 ). (cdc.gov)
  • Persons are more likely to have Lynch syndrome if they or their close relatives have had colorectal, endometrial, or ovarian cancers, especially at younger ages ( 7 ). (cdc.gov)
  • The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group † recommends that persons with newly diagnosed colorectal cancer be offered genetic testing for Lynch syndrome to reduce morbidity and mortality in their close relatives ( 10 ). (cdc.gov)
  • Persons with Lynch syndrome can talk to their health care provider about starting screening for colorectal cancer with colonoscopy at a younger age and screening more frequently than persons who are at average risk ( 10 ). (cdc.gov)
  • Pancreatic carcinoma is very rare in children. (cancer.gov)
  • When a tumor forms in one of these clusters, it's called a pancreatic NET, or islet cell carcinoma. (hopkinsmedicine.org)
  • The aim of this study was to characterize the expression of DcR3 in pancreatic carcinoma and to evaluate the role of DcR3 in cell proliferation and apoptosis, which may lead to the development of novel treatments for this disease. (academicjournals.org)
  • Pancreatic carcinoma is one of the most enigmatic and aggressive malignant diseases. (proteinlounge.com)
  • Hepatocellular Carcinomas from Iran: Evidence study of lung cancer among European asphalt carcinoma among postmenopausal women in the for Lack of Association between HBV Genotype workers. (who.int)
  • Cancer Lett, 300:215-224.doi:10.1016/j. squamous cell carcinoma in north-eastern Iran. (who.int)
  • 99:209 -215.doi:10.1007/s11060 - 010 - 0129 -5 cell carcinoma-a population-based study in with and without cervical cancer in Tbilisi, Georgia. (who.int)
  • About 80% of all newly diagnosed breast cancers have luminal cell phenotype and they express estrogen receptor (ERα). (nature.com)
  • Among newly diagnosed patients with pancreatic cancer, which of the following clinical examination findings is most commonly noted? (medscape.com)
  • Exosomal miR-139 derived from cancer-associated fibroblasts inhibited gastric cancer progression by suppressing matrix metallopeptidaseBioengineering 2021, 8,4 ofexpression [55]. (glucagon-receptor.com)
  • Moreover, both angiotensin receptors (AT1 and AT2) are overexpressed in different types of cancers, which confirms the role of local RAS in cancer development and progression ( 3 , 5 - 8 ). (spandidos-publications.com)
  • The horizontal blue bars represent specific mutated genes that aid in the progression of the cancer during specific portions of its development. (medscape.com)
  • Her focus of research is the role of estrogen and thyroid hormones in colon cancer progression and their effects on inflammatory components of the tumor microenvironment, in a big female cohort. (lu.se)
  • There are more than 250,000 cases of pancreatitis in the United States each year and 50,000 cases of pancreatic cancer per year," he said. (ascopost.com)
  • The American Cancer Society estimated that in 2022, there would be 62,210 new cases of pancreatic cancer and 49,830 deaths from pancreatic cancer (25,970 in men and 23,860 in women). (medscape.com)
  • A clinical trial was conducted in a single patient with pancreatic cancer that had metastasized to the lungs. (cytologicsbio.com)
  • There are seven major challenges for every patient with pancreatic cancer that we need to address in order to provide them with the most help. (ascopost.com)
  • Breast cancers are commonly divided into four molecular subtypes based on specific therapeutically actionable biomarkers and gene expression profiles 1 . (nature.com)
  • Molecular oncology in lung cancer - between biomarkers and clinical application. (springermedizin.at)
  • Cancer Epidemiol Biomarkers Prev. (vitamindwiki.com)
  • The U.S. Food and Drug Administration today approved the cobas EGFR Mutation Test v2, a blood-based companion diagnostic for the cancer drug Tarceva (erlotinib). (news-medical.net)
  • A major barrier to the understanding of the ERα-pathway biology and therapeutic discoveries is the restricted repertoire of luminal ERα + breast cancer models. (nature.com)
  • To investigate the in vitro effects of suicide gene therapy system of herpes simplex virus thymidine kinase gene (HSV-TK) in combination with the treatment of nucleotide analog-ganciclovir (GCV) on human pancreatic cancer, and to provide a novel clinical therapeutic method for human pancreatic cancer. (wjgnet.com)
  • Despite of the development in the three routine therapeutic methods of surgery[ 3 ], chemotherapy, and radiotherapy, the cure rate for pancreatic cancer has improved only minimally, and the overall survival of patients remains dismal. (wjgnet.com)
  • Plants are natural reservoirs of novel compounds and provide a promising therapeutic approach for treatment of cancer. (researchsquare.com)
  • Our results also imply that TrkB receptor may be a novel therapeutic target for pancreatic cancer. (duke.edu)
  • 5B1 is also being studied as a potential therapeutic for patients with pancreatic cancer in early-phase clinical trials," he said. (ascopost.com)
  • Turning the heat up on pancreatic cancer: Lessons on overcoming a "cold" immunologic microenvironment [abstract]. (aacrjournals.org)
  • Tests that examine the pancreas are used to help diagnose pancreatic cancer. (cancer.gov)
  • The image in the slide shows a gross section of a cancerous pancreas measuring 5 × 6 cm that has been resected from the pancreatic body. (medscape.com)
  • In 2017, the Pancreatic Cancer Action Network (PanCAN), in partnership with generous donors, awarded 17 grants to 21 researchers at 12 institutions for a projected investment of $4.9 million to support pancreatic cancer research across the country. (pancan.org)
  • Pancreatic NETs can be either benign (non-cancerous) or malignant (cancerous), although both types can cause serious health problems. (hopkinsmedicine.org)
  • Malignant pleural mesothelioma (MPM) is an aggressive inflammatory cancer with a poor survival rate. (frontiersin.org)
  • People with some other inherited syndromes, such as von Hippel Lindau (VHL) syndrome and neurofibromatosis type 1 (NF1), also have an increased risk of pancreatic NETs. (hopkinsmedicine.org)
  • Plasma 25-Hydroxyvitamin D and Risk of Pancreatic Cancer. (vitamindwiki.com)
  • To determine whether prediagnostic levels of plasma 25-hydroxyvitamin D (25[OH]D) were associated with risk of pancreatic cancer, we performed a nested case-control study of 451 cases and 1167 controls from five cohorts through 2008. (vitamindwiki.com)
  • Signs and symptoms of pancreatic cancer include feeling tired and weight loss. (cancer.gov)
  • Specific symptoms of pancreatic NETs are different, depending on what type you have. (hopkinsmedicine.org)
  • The incidence of PDAC is increasing progressively, such that PDAC may become the leading cause of cancer-related deaths in the United States by 2050. (nih.gov)
  • Laboratory data confirm a beneficial role of metformin in reducing or preventing PDAC, and suggest that GLP-1 receptor agonists may increase the risk of PDAC. (nih.gov)
  • CHICAGO - Patients with resectable, early-stage pancreatic cancer can safely undergo minimally invasive distal pancreatectomy (MIDP) as an alternative to traditional open surgery, suggest results from the international DIPLOMA study. (medscape.com)
  • This confirmatory study proves that minimally invasive surgical techniques are a safe and effective option for resectable pancreatic cancer," commented ASCO expert Jennifer F. Tseng, MD, chair of surgery at Boston Univesrity School of Medicine and surgeon-in-chief at the Boston Medical Center. (medscape.com)
  • In patients with chronic pancreatitis with an increased risk for pancreatic cancer, the biomarker signature detected 98% of resectable pancreatic cancers (55 out of 78, stages IA to IIB) with an accuracy of 90.4%," the researchers report, adding that "this can be regarded as a significant advance in the field. (medscape.com)
  • In the patients with pancreatic cancer, blood was drawn as presurgical samples in 135 patients who had resectable disease and as prechemotherapy samples in 136 patients with unresectable pancreatic cancer. (medscape.com)
  • Mesothelin-redirected chimeric antigen receptor T cell (meso-CAR T cell) therapy has shown some efficacy in clinical trials but antitumor efficacy remains modest. (jci.org)
  • The research data obtained in these one-patient clinical trials warrant additional studies with more participants to determine the efficacy and safety of neoantigen T-cell receptor gene therapy for pancreatic and other mutant KRAS-expressing cancers. (cytologicsbio.com)
  • it can be distinguished from those cancer types both by molecular footprint and clinical presentation. (wikipedia.org)
  • As part of our mission to eliminate cancer, MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers. (mdanderson.org)
  • Here, we combine spatial transcriptomics and scRNA-Seq datasets to define the transcriptome of tumor-proximal and tumor-distal cancer-associated fibroblasts (CAFs) and link this to clinical outcome. (elifesciences.org)
  • CONCLUSION: These results suggest that overexpression of TrkB and activation of mitogen-activated protein kinase and AP-1, which may in turn induce the expression of vascular endothelial growth factor and interleukin 8, may mediate the cardinal clinical features of locally aggressive growth and metastasis of pancreatic cancer. (duke.edu)
  • Drawing on several lines of ongoing research, David A. Tuveson, MD, PhD , has created a theoretical framework to consider while developing clinical trials in pancreatic cancer. (ascopost.com)
  • Clinical cancer research : an official journal of the American Association for Cancer Research. (rochester.edu)
  • Most endometrial cancer cases are diagnosed in the early stages and therefore result in favourable clinical outcomes ( 2 ). (spandidos-publications.com)
  • The biomarker signature includes 9 metabolites as well as the carbohydrate antigen 19-9 (CA19-9), which is currently the only blood-based biomarker in clinical use for pancreatic cancer. (medscape.com)
  • Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer. (cdc.gov)
  • Aberrant platelet-derived growth factor receptor beta (PDGFRβ) signaling in cancer has motivated the development of several antagonists currently in clinical use, including imatinib, sunitinib, and sorafenib. (lu.se)
  • IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer. (nih.gov)
  • Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer. (rochester.edu)
  • The tumor microenvironment in the context of colon cancer and with a focus on the inflammatory mediators leukotriene D 4 (LTD 4 ) and prostaglandins (PGE 2 ) and their respective receptors. (lu.se)
  • Our aim is to generate solid support for novel and complementary treatments of colon cancer patients that focus on the inflammatory component of the tumor microenvironment. (lu.se)
  • I am interested in colon cancer, one of the most common cancers in the world, and specifically how the microenvironment and cancer interact with one another. (lu.se)
  • We investigate how the lack of these receptors affects tumour growth and the surrounding tumour microenvironment in different colon cancer models. (lu.se)
  • Puja has done her first post-doctoral training on the cross-talk between pancreatic cancer and its microenvironment. (lu.se)
  • However, knowledge of the contribution of MUC16 to pancreatic tumorigenesis is limited. (unc.edu)
  • Cancer Facts & Figures 2022. (medscape.com)
  • Available at https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2022/2022-cancer-facts-and-figures.pdf . (medscape.com)
  • The Pancreatic Cancer Market is anticipated to reach USD 2,430.43 Million by 2030 at 7.40% CAGR during the forecast period 2022-2030. (marketresearchfuture.com)
  • A collaboration of scientists from Earle A. Chiles Research Institute of the Providence Cancer Institute and the National Cancer Institute previously identified T-cell receptors that target KRAS G12D, a "hot spot" signaling protein mutation found in certain cancers. (cytologicsbio.com)
  • This gene encodes a member of the beta chemokine receptor family, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. (cancerindex.org)
  • The ligand of this receptor is macrophage inflammatory protein 3 alpha (MIP-3 alpha). (cancerindex.org)
  • DcR3 protein in our experimental results showed significant expression among the pancreatic cancer cell lines and their decreased expression by lentivirus-mediated shRNA resulted in the inhibition of cell proliferation and augmentation of apoptosis. (academicjournals.org)
  • The interleukin 20 receptor is a heterodimeric complex consisting of the encoded protein and interleukin 20 receptor beta. (nih.gov)
  • A gene known as TJP1 (tight junction protein 1) could help determine which multiple myeloma patients would best benefit from proteasome inhibitors such as bortezomib, as well as combination approaches to enhance proteasome inhibitor sensitivity, according to a study led by The University of Texas MD Anderson Cancer Center. (news-medical.net)
  • E7 from human papil omavirus type 16 cooperate to cancer: the European prospective investigation into doi:10.1093/carcin/bgp321 PMID:20047954 target the PDZ protein Na/H exchange regulatory cancer and nutrition study. (who.int)
  • such receptors include endothelial receptor of protein C (ePCR), gC1qR, intercellular adhesion molecule-1, CD36, chondroitin sulfate A, or complement receptor 1 ( 10 ). (cdc.gov)
  • Lubnas research is mainly focused on the tumor suppressor protein 15-hydroxyprostaglandin dehydrogenase which is known to be down-regulated in colon cancer. (lu.se)
  • Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic Cancer. (rochester.edu)
  • Hospitals were overwhelmed with COVID-19 patients, and they were, therefore, unable to treat pancreatic cancer patients properly! (marketresearchfuture.com)
  • It is also used together with gemcitabine to treat pancreatic cancer and is being studied in the treatment of other types of cancer. (news-medical.net)
  • When separating out patients who have pancreatic cancer from those who have benign pancreatic disease, the test's sensitivity is 78.2% and its specificity is 82.8%, the researchers point out. (medscape.com)
  • Similar to TNBC, as opposed to hormone receptor-positive breast cancer, there is a high rate of relapse and metastasis in the first three years after presentation, with few late events (five years or later). (wikipedia.org)
  • Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread. (mdanderson.org)
  • EXPERIMENTAL DESIGN: To identify the genes involved in pancreatic cancer metastasis, we analyzed the gene expression profiles between highly metastatic Colo357L3.6pl and parental Colo357FG pancreatic cancer cell lines using cDNA microarrays and confirmed differential gene expression by reverse transcription-PCR, Western blotting, and immunologic analysis of 54 samples from pancreatic cancer patients. (duke.edu)
  • Cancer Immunol Res (2020) 8 (4_Supplement): IA01. (aacrjournals.org)
  • In his keynote lecture at the 2020 American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer, "Overcoming the Seven Deadly Hallmarks of Pancreatic Cancer," he provided a road map for tackling the disease. (ascopost.com)
  • The images in the slide are of cytologic samples from fine-needle aspiration (FNA) of pancreatic adenocarcinomas: (A) well-differentiated tumor, (B) moderately differentiated tumor, (C) moderately to poorly differentiated tumor, and (D) poorly differentiated tumor. (medscape.com)
  • Endocr Relat Cancer, 2018 Sep. (nih.gov)
  • We examine 400 patient-derived breast epithelial and breast cancer explant cultures (PDECs) grown in various three-dimensional matrix scaffolds, finding that ERα is primarily regulated by the matrix stiffness. (nature.com)
  • NGF level was preeminently higher in PC tissues and cell lines than in paracarcinoma tissues and normal pancreatic epithelial cell lines. (hindawi.com)
  • A Systematic Review of Mesenchymal Epithelial Transition Factor (MET) and Its Impact in the Development and Treatment of Non-Small-Cell Lung Cancer. (lu.se)
  • After Ang II treatment, poorly differentiated endometrial cancer cell line acquired a mesenchymal phenotype, which was characterized by induced expression of EMT-related genes (VIM, CD44, SNAI1, ZEB1 and ZEB2). (spandidos-publications.com)
  • Moreover, we examined alterations in the expression of genes related to cancer cell behaviour after Ang II treatment. (spandidos-publications.com)
  • Cancer genomics analysis revealed that 36 of the most differentially expressed mRNAs were involved in a pancreatic cancer network and were associated with many critical mutated genes such as TP53, KRAS, SMAD4, and CDKN2A. (jcancer.org)
  • Activin receptor-like kinase 7 silencing alleviates cardiomyocyte apoptosis, cardiac fibrosis, and dysfunction in diabetic rats. (nih.gov)
  • MST1R (RON) is a trans-membrane receptor tyrosine kinase (RTK), which is part of the c-MET proto-oncogene family. (frontiersin.org)
  • 2010). Polycyclic aromatic hydrocarbon exposure standard mammogram form and the interactive kinase in response to estradiol in breast cancer in oesophageal tissue and risk of oesophageal threshold measurement methods. (who.int)
  • 11 weeks, enrolling patients with type 2 diabetes and comparing a GLP-1 receptor agonist with placebo or any other non-GLP-1 receptor agonist drug. (nih.gov)
  • Despite the promising outcomes for some patients treated with these approaches, some forms of cancer, such as pancreatic cancer, seem resistant. (cytologicsbio.com)
  • Only around 12% of patients with pancreatic cancer are diagnosed when the disease is at an early enough stage for surgical resection to be a possibility, Hilal noted. (medscape.com)
  • Pancreatic cancer is an aggressive malignancy with less than 5% of the patients alive at 5 years and 92% of the patients dead at 2 years[ 1 , 2 ]. (wjgnet.com)
  • Your gift will help support our mission to end cancer and make a difference in the lives of our patients. (mdanderson.org)
  • relied on tumour samples obtained from pancreatic cancer patients. (elifesciences.org)
  • We have to take the inflammation hallmark of pancreatitis seriously and study blocking and dampening it in patients with pancreatic cancer. (ascopost.com)
  • So, this is a subgroup of patients with pancreatic cancer who present with jaundice. (webofstories.com)
  • Identification of a specific genetic mutation in patients with non-small-cell lung cancer (NSCLC) helps clinicians select the best treatment option. (news-medical.net)
  • In a study appearing in the May 3 issue of JAMA, Pascal Hammel, M.D., of Beaujon Hospital, Clichy, France and colleagues assessed whether chemoradiotherapy improves overall survival of patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine-based induction chemotherapy, and assessed the effect of erlotinib on survival. (news-medical.net)
  • Continued exposure to afatinib plus paclitaxel can benefit non-small-cell lung cancer patients who developed resistance to erlotinib or gefitinib and progressed after initially responding to afatinib monotherapy, suggest phase III trial results. (news-medical.net)
  • however, patients diagnosed with pancreatic cancer remain extremely vulnerable to relapse and death. (jcancer.org)
  • [1] The overall average 5-year survival rate for patients with pancreatic cancer is 11%, though survival is highly dependent on staging. (medscape.com)
  • Jaundice and weight loss are the most common symptoms plaguing patients with pancreatic cancer. (medscape.com)
  • Although surgical resection can be applied when the tumor is well defined (20% of cases) 1 , most patients with pancreatic cancer are treated with chemotherapy. (isciii.es)
  • Theoretically, the latter patients would have undergone unnecessary pancreatic resection with a reported mortality of up to 8%," they note. (medscape.com)
  • Conversely, the new test identified 15% more patients in whom the diagnosis of pancreatic cancer was missed with standard diagnostic methods. (medscape.com)
  • Previously, it has been reported that CA19-9 has a sensitivity of 80.3% and a specificity of 80.2% when discriminating between patients with pancreatic cancer and healthy controls. (medscape.com)
  • High levels of 15-PGDH correlates with longer survival of colon cancer patients. (lu.se)
  • Her research involves methods as tissue microarray (TMA) of colon cancer patients for immunohistochemistry (IHC) and Western blot, qPCR, transfection, luciferase assay, immunofluorescens on colon cancer cell lines. (lu.se)
  • Through the collection and evaluation of a family cancer history by a trained health care provider, patients and families at increased risk for a hereditary cancer syndrome can be identified, referred for genetic counseling and testing, and make informed decisions about options for cancer risk reduction ( 1 ). (cdc.gov)
  • La présente analyse récapitule les facteurs pathologiques majeurs liant l'obésité au diabète, en se concentrant sur les données épidémiologiques actuelles relatives aux patients diabétiques obèses dans le monde arabe, l'étiologie de la maladie et les déterminants génétiques du diabète et de l'obésité. (who.int)
  • This gene and interleukin 20 receptor beta are highly expressed in skin, and are upregulated in psoriasis. (nih.gov)
  • Pancreatic cancer is a devastating disease with a low five-year survival rate. (jcancer.org)
  • Pancreatic cancer is a devastating disease that is difficult to diagnose, which helps to explain the 10% five-year survival rate [ 1 ]. (jcancer.org)
  • Inhibits PK2-induced expression of pro-migratory chemokines and chemokine receptors in macrophages. (rndsystems.com)
  • The commonness of ERα positive luminal breast cancer together with the effectiveness and widespread use of ERα pathway inhibitors in treatment predicts that this biology will remain the major focus of research and drug development. (nature.com)
  • It has been reported that signaling from the nerve growth factor (NGF) pathway associated with peripheral nerves is able to contribute to perineural invasion (PNI) of pancreatic cancer (PC). (hindawi.com)
  • Available at http://www.cancer.org/cahttps://www.cancer.org/cancer/types/pancreatic-cancer/detection-diagnosis-staging/staging.html . (medscape.com)
  • American Joint Committee on Cancer (AJCC) TNM staging system, September 6, 2013. (medscape.com)
  • Available at http://www.cancer.org/cancer/pancreaticcancer/detailedguide/pancreatic-cancer-staging. (medscape.com)
  • Persons are more likely to have a BRCA1 or BRCA2 mutation if they or their close relatives on either their mother's or father's side of the family have had breast cancer before age 50 years, triple negative breast cancer,* ovarian cancer, cancer in both breasts, breast cancer in a male relative, or multiple relatives with breast, pancreatic, or high grade prostate cancer ( 2 ). (cdc.gov)
  • WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer. (who.int)
  • Nivolumab has been approved since April 2016 as a checkpoint inhibitor for the treatment of adults with locally advanced or metastatic nonsquamous non-small-cell lung cancer (NSCLC) who have already undergone chemotherapy. (news-medical.net)
  • Afatinib (trade name: Giotrif) has been approved since April 2016 for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) of squamous histology who have already received chemotherapy. (news-medical.net)
  • Moreover, approximately 53,070 Americans were predicted to have been diagnosed with pancreatic cancer, and approximately 41,780 Americans were predicted to have died of pancreatic cancer in 2016. (jcancer.org)
  • This was because people suffering from pancreatic cancer were unable to get the proper diagnosis and care needed to treat the disease. (marketresearchfuture.com)
  • All components of the RAS (angiotensinogen, angiotensin converting enzyme, angiotensin receptors) are expressed in many types of tumours, including endometrial cancer ( 2 , 4 ). (spandidos-publications.com)
  • Erlotinib has been approved by the FDA for use, in combination with gemcitabine, as a first-line treatment for locally advanced, unresectable, or metastatic pancreatic cancer. (medscape.com)
  • The treatment for pancreatic NET varies based on the type of NET that you have. (hopkinsmedicine.org)
  • In conclusion, these findings suggest that lentivirus-mediated gene therapy targeting DcR3 is a potential and attractive strategy for the treatment of pancreatic cancer. (academicjournals.org)
  • Our data demonstrate that HSV-TK/GCV suicide gene therapy system is effective for treating experimental human pancreatic cancer, which is largely resistant to the common therapies, so the suicide gene therapy system may be a potential treatment approach for pancreatic cancer. (wjgnet.com)
  • Naturally occurring compounds from plants known as phytochemicals, fill in as indispensable assets for novel medications and are likewise rich sources for cancer treatment. (researchsquare.com)
  • It is developed based on PurAffin technology.It was also under development for the treatment of small-cell lung cancer. (globaldata.com)
  • New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy. (rochester.edu)
  • Many people in developed nations (even those with good insurance policies) find that it is difficult to afford treatment for pancreatic cancer. (marketresearchfuture.com)
  • Breast Cancer Research and Treatment. (healthpartners.com)
  • Pancreatic cancer treatment in advanced stages is based on different chemotherapy regimens. (isciii.es)
  • The current treatment of pancreatic cancer, the 9th most frequent and 4th deadliest type of cancer, remains ineffective. (isciii.es)
  • PanIN = pancreatic intraepithelial neoplasia. (medscape.com)
  • Two hereditary cancer syndromes for which public health professionals have worked to reduce the burden of morbidity and mortality are hereditary breast and ovarian cancer syndrome (HBOC) and Lynch syndrome. (cdc.gov)
  • Mutation carriers face a substantially higher risk for developing breast and ovarian cancers by age 70 years than do women in the general population ( Table 1 ) ( 4 , 5 ). (cdc.gov)
  • Development of an Orthotopic Murine Model of Rectal Cancer in Conjunction With Targeted Short-Course Radiation Therapy. (rochester.edu)
  • Exhibits antitumor activity against glioblastoma and pancreatic cancer xenograft tumor models. (rndsystems.com)
  • Bladder Cancer Extracellular Vesicles Elicit a CD8 T Cell-Mediated Antitumor Immunity. (rochester.edu)
  • The receptor then returns to the cell membrane surface. (joplink.net)
  • The establishment of ERα + luminal breast cancer cell lines has turned out to be a challenging task for reasons not entirely clear. (nature.com)
  • Studies on the transcriptomic profiles of the clonal luminal breast cancer cell lines suggest that these cell lines do not recapitulate well the established luminal tumor subtype 7 . (nature.com)
  • Therefore, widespread use of few ERα + luminal cell lines generate an information bias towards the specific clonal genetic makeup of these cell lines and their other attributes, which may not possibly apply to luminal ERα + breast cancer in general. (nature.com)
  • In the present study, we examined five cell lines including three cell lines from pancreatic cancer (SW1990, Capcan-1 and PANC-1) and two cell lines from colon cancer (HCT116 and RKO) for DcR3 expression by reverse transcriptase-polymerase chain reaction (RT-PCR) and quantitative real time PCR. (academicjournals.org)
  • The human pancreatic cancer Capan-1 cell line was first infected with lentivirus-mediated shRNA and then analyzed by real-time PCR, and the results were further confirmed by Western blotting. (academicjournals.org)
  • Cancer Cell 24, 1-13, 2013. (mdanderson.org)
  • A PK2/Bv8/PROK2 antagonist suppresses tumorigenic processes by inhibiting angiogenesis in glioma and blocking myeloid cell infiltration in pancreatic cancer. (rndsystems.com)
  • Laboratory studies suggest vitamin D may inhibit pancreatic cancer cell growth. (vitamindwiki.com)
  • Therefore, various biologically active peptides such as angiotensin, affecting cell proliferation, have become a new area of study in endometrial cancer research. (spandidos-publications.com)
  • Erlotinib is a drug used to treat certain types of non-small cell lung cancer. (news-medical.net)
  • Transcriptomic profiling of T-cell populations in non-muscle invasive and muscle invasive bladder cancer. (lu.se)
  • The biomarker signature distinguished pancreatic cancer from chronic pancreatitis, assuming a cumulative incidence of 1.95%, with an area under the curve of 0.96, a sensitivity of 89.9%, and a specificity of 91.3%, the researchers report. (medscape.com)
  • One pill every two weeks fights diabetes, cancers, heart failure, and 21 other diseases. (vitamindwiki.com)
  • Obesity, Type 2 diabetes and metabolic syndrome, all of which have risen to epidemic levels in recent years, are linked to pancreatic cancer. (vitamindwiki.com)
  • This gene encodes a member of the type II cytokine receptor family. (nih.gov)
  • A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling. (nih.gov)
  • A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis. (mdanderson.org)